U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Furosemide Injection
Status: Currently in Shortage
»Date first posted: 04/07/2020
»Therapeutic Categories: Cardiovascular

Expand all

Accord Healthcare Inc. (New 03/27/2023)

Company Contact Information:
866-941-7875

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/ml (SDV) USP; 20 mg/2 ml; 25 pk [2 ml] Vial (NDC 16729-500-08) Unavailable Inventory on hold pending further assessment. Other
10 mg/ml (SDV) USP; 40 mg/4 ml; 10 pk [4 ml] Vial (NDC 16729-501-43) Unavailable Inventory on hold pending further assessment. Other
10 mg/ml (SDV) USP; 100 mg/10 ml; 10 pk [10 ml] Vial (NDC 16729-502-43) Unavailable Inventory on hold pending further assessment. Other

Athenex Pharmaceutical Division, LLC (Athenex) (Reverified 03/24/2023)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/2mL vial (NDC 70860-302-41 and 70860-302-02) Available
40 mg/4mL vial (NDC 70860-302-42 and 70860-302-04) Available
100 mg/10mL vial (NDC 70860-302-43 and 70860-302-10) Available

Avet Pharmaceuticals Inc (Revised 10/31/2022)

Company Contact Information:
855-228-9470

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/mL (NDC 23155-473-41) Available
40 mg/4mL (NDC 23155-473-42) Available
100 mg/10mL (NDC 23155-473-44) Available

Baxter Healthcare (Reverified 03/29/2023)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Furosemide Injection, USP, 10 mg/mL - 10 mL Single Dose Glass Vial (25 x 10 mL) (NDC 36000-284-25) Available
Furosemide Injection, USP, 10 mg/mL - 2 mL Single Dose Glass Vial (25 x 2 mL)(NDC 36000-282-25) Available
Furosemide Injection, USP, 10 mg/mL - 4 mL Single Dose Glass Vial (25 x 4 mL)(NDC 36000-283-25) Available

Eugia Pharma Specialties LTD. (formerly Aurobindo) (Reverified 03/17/2023)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/2 mL single-dose vial (NDC 55150-322-25) Currently on backorder - next shipment TBD Delay in shipping of the drug
40 mg/4 mL single-dose vial (NDC 55150-323-25) Currently on backorder, next shipment TBD Delay in shipping of the drug
100 mg/10 mL single-dose vial (NDC 55150-324-25) Currently on backorder, next shipment TBD Delay in shipping of the drug

Fresenius Kabi USA, LLC (Revised 03/31/2023)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02) Available Check wholesalers for inventory. Demand increase for the drug
40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04) Backordered. Next release April 2023. Demand increase for the drug
100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10) Available Check wholesalers for inventory. Demand increase for the drug

Gland Pharma Limited (Reverified 07/01/2022)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mL in 1 vial, 25 vials/carton (NDC 25021-311-02) Available Demand increase for the drug
4 mL in 1 vial, 25 vials/carton (NDC 25021-311-04) Available Demand increase for the drug
10 mL in 1 vial, 25 vials/carton (NDC 25021-311-10) Available Demand increase for the drug

Hospira, Inc., a Pfizer company (Revised 03/31/2023)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-02) Available Other
40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-04) Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial (NDC 0409-6102-10) Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-25) Available Other
40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-26) Available Other
100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-27) Next Delivery: April 2023; Estimated Recovery: June 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other

Meitheal Pharmaceuticals, Inc. (Reverified 02/13/2023)

Company Contact Information:
844-824-8426

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg per 2 mL (NDC 71288-205-03) Available
40 mg per 4 mL (NDC 71288-203-05) Available
100 mg per 10 mL (NDC 71288-203-11) Available

Sagent Pharmaceuticals (Reverified 03/22/2023)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/2 mL single-dose vial (NDC 25021-311-02) Available.
40 mg/4 mL single-dose vial (NDC25021-311-04) Available.
100 mg/10 mL single-dose vial (NDC 25021-311-10) Available
Back to Top